Incyte Corp. reported that the monoclonal antibody Zynyz had received expedited approval from the U.S. health regulator for the treatment of an aggressive and rare adult skin cancer. The treatment was approved by the Food and Drug Administration of the United States for patients with Merkel cell carcinoma (MCC) whose cancer has recurred or spread […]
Continue Reading
The majority of patients infected with Pseudomonas aeruginosa reported using artificial tears or eyedrops, according to the Centers for Disease Control and Prevention (CDC). This drug-resistant strain of bacteria caused severe injuries to 68 patients across the United States, including three deaths. According to the CDC, these cases involved ten distinct ophthalmic drug brands. Ezri […]
Continue Reading
AbbVie announced that the FDA has rejected its application for ABBV-951 to control motor fluctuations in advanced Parkinson’s disease patients. Foscarbidopa and foslevodopa, the prodrugs for the widely used carbidopa and levodopa, respectively, are already included in AbbVie’s Duopa as part of the treatment. Prodrugs are versions of drugs that work once they are in […]
Continue Reading
The pharmaceutical company Lupin made the announcement that its alliance partner Caplin Steriles’ multiple-dose vials of Thiamine Hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) had been granted approval by the United States Food and Drug Administration (US FDA). According to IQVIA MAT for the twelve months ending December 2022, sales of Thiamine Hydrochloride Injection […]
Continue Reading
In a decision that could limit access to the drug nationwide, a Texas judge heard arguments about whether a commonly used abortion pill should be sold in the United States. Mifepristone, a pill that can be taken at home, is used in more than half of all pregnancy terminations in the United States. A claim […]
Continue Reading
Plans to establish new partnerships with other international drug regulators could result in the approval of new drugs for use in the UK. The UK regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), will receive 10 million pounds to assist in streamlining the approval process for new medical products, according to Chancellor Jeremy Hunt. […]
Continue Reading
India is experiencing a rapid spread of the H3N2 influenza virus. The country has seen a significant increase in the number of cases of the infection over the past few days. This infection is almost identical to the COVID-19 infection, but their natures are very different. Up until March 9th, 2023, the states reported a […]
Continue Reading
The omicron single-dose booster shot for children under the age of five was approved by Pfizer and its partner BioNTech SE by the US Food and Drug Administration (FDA). According to the agency, children who have already received three doses of the initial vaccine will be eligible for the booster. After receiving the clinical trial […]
Continue Reading
Glenmark Pharma has announced that the US Food and Drug Administration (USFDA) has granted it permission to distribute a generic version of Pfizer’s antibiotic Cleocin capsules. Clindamycin Hydrochloride Capsules with potencies of 75 mg, 150 mg, and 300 mg will be distributed in the United States by Glenmark Pharmaceuticals Inc, an Indian subsidiary. This endorsement […]
Continue Reading
Pharma giant Pfizer announced that a first-of-its-kind fast-acting nasal spray for treating migraines has been approved by the US Food and Drug Administration (FDA). In a statement, Pfizer said that it expects the drug Zavzpret to be in pharmacies in July 2023. Angela Hwang, the chief commercial officer of the pharmaceutical company, said that, the […]
Continue Reading